MORRISVILLE, N.C.--(BUSINESS WIRE)--Arrivo Bio announced today a significant step forward in the fight against major depressive disorder (MDD) with the dosing of the first patient in the SP-624-202 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback